Last reviewed · How we verify
NCT05699369
Interventions to Improve Non-communicable Disease Management During the Pandemic
NA trial testing Digital health interventions in Noncommunicable Diseases in 1,500 participants. Status unknown.
15 February 2024
Quick facts
| Lead sponsor | University of Toronto |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | health services research |
| Enrollment | 1,500 |
| Start date | 25 January 2023 |
| Primary completion | 15 February 2024 |
| Estimated completion | 15 February 2024 |
| Sites | 1 location across Pakistan |
Drugs / interventions tested
- Digital health interventions
Conditions studied
- Noncommunicable Diseases — all drugs for Noncommunicable Diseases →
- COVID-19 — all drugs for COVID-19 →
Sponsor
University of Toronto
Who can join
25 and older, any sex, with Noncommunicable Diseases or COVID-19. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This randomized controlled trial aims to implement and evaluate a comprehensive package of digital health interventions for integrated COVID-non-communicable diseases (NCDs) care to manage NCDs in primary care facilities in rural Pakistan. The main questions it aims to answer are 1) whether such interventions are effective; 2) how they were implemented; and 3) whether such interventions are cost-effective. 30 rural health centers in Punjab Province, Pakistan will be randomized into two groups. The intervention group will provide a comprehensive package of digital health interventions to connect patients, patient champions, and public health providers to improve the management of NCDs during the pandemic, including 1) providing training to health providers regarding an integrated NCD-COVID guideline; 2) using a smartphone app to improve NCD case management and linking with patient champions; and 3) employing telementoring platform to improve quality of care. Usual care will be provided in the control group. Researchers will compare the two groups to see if the systolic blood pressure can be controlled better in the intervention group at 10 months.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Protocol for a pragmatic cluster randomised controlled trial to evaluate the effectiveness of digital health interventions in improving non-communicable disease management during the pandemic in rural Pakistan.
Wei X, Khan N, Durrani H, Muzaffar N, et al · · 2023 · cited 2× · PMID 37816010 · DOI 10.1371/journal.pone.0282543 -
Protocol for a cluster randomised controlled trial to evaluate the effectiveness of digital health interventions in improving non-communicable disease management during the pandemic in rural Pakistan
Wei X, Khan N, Durrani H, Muzaffar N, et al · · 2023 · DOI 10.1101/2023.02.17.23286113
Verify or expand the search:
- PubMed search for NCT05699369
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Noncommunicable Diseases
Currently open trials in the same condition.
- NCT05009433 — HIIT vs MICT During Pregnancy and Health and Birth Outcomes in Mothers and Children · NA · recruiting
- NCT05248412 — The Long-term Spill-over Impact of COVID-19 on Health and Healthcare of People With Non-communicable Diseases · recruiting
Other University of Toronto trials
Trials by the same sponsor.
- NCT07184255 — Animated Video Education for Retinal Surgery · NA · not yet recruiting
- NCT07259434 — Time Restricted Eating in Survivors Trial 2.0 · NA · not yet recruiting
- NCT07486050 — The Impact of Social Worker Referrals on Diabetes and Loneliness · NA · active not recruiting
- NCT07268729 — Investigation of Pathogenic Gut Microbiota Patterns in Anxiety, Depression and Panic Disorders · not yet recruiting
- NCT07317921 — Validating IAAO for Muscle Outcomes · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05699369 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Toronto
- Last refreshed: 10 May 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05699369.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing